679
Views
10
CrossRef citations to date
0
Altmetric
Review Articles:Gynaecology

Ever-use of the intra-uterine device and the risk of ovarian cancer

, ORCID Icon, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katherine Ogle & Ariel B. Handy. (2023) The Effects of Hormonal and Non-Hormonal Intrauterine Devices on Female Sexual Function: A Systematic Review. International Journal of Sexual Health 35:1, pages 67-81.
Read now
Yupei Shen, Xiaoli Liu, Linfen Xu, Weiqiang Zhu, Zhaofeng Zhang, Junwei Liu, Lifang Jiang, Yanyan Mao, Jianhua Xu, Xiaoqin Yan, Junjie Sun, Fang Liu, Xiumei Xiong, Xiujuan Chen, Yan Che & Jing Du. (2022) Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device. Personalized Medicine 19:6, pages 523-534.
Read now

Articles from other publishers (8)

Penelope M. Webb & Susan J. Jordan. (2024) Global epidemiology of epithelial ovarian cancer. Nature Reviews Clinical Oncology 21:5, pages 389-400.
Crossref
Nicole Minalt, Amy Caldwell, Grace M. Yedlicka, Sophia Joseph, Sharon E. Robertson, Lisa M. Landrum & Jeffrey F. Peipert. (2023) Association between intrauterine device use and endometrial, cervical, and ovarian cancer: an expert review. American Journal of Obstetrics and Gynecology 229:2, pages 93-100.
Crossref
Bi Peng, Jing Li, Yuanliang Yan, Yuanhong Liu, Qiuju Liang, Wei Liu, Abhimanyu Thakur, Kui Zhang, Zhijie Xu, Jian Wang & Fan Zhang. (2023) Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response. Frontiers in Pharmacology 14.
Crossref
Majke H D van Bommel, Joanna IntHout, Guus Veldmate, C Marleen Kets, Joanne A de Hullu, Anne M van Altena & Marline G Harmsen. (2023) Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis . Human Reproduction Update 29:2, pages 197-217.
Crossref
Yue Yin Xia & Joanne Kotsopoulos. (2022) Beyond the pill: contraception and the prevention of hereditary ovarian cancer. Hereditary Cancer in Clinical Practice 20:1.
Crossref
Lauren Clarfield, Laura Diamond & Michelle Jacobson. (2022) Risk-Reducing Options for High-Grade Serous Gynecologic Malignancy in BRCA1/2. Current Oncology 29:3, pages 2132-2140.
Crossref
Gloria D’Alessandro, Matteo Frigerio, Fabio Barra, Sergio Costantini, Claudio Gustavino & Simone Ferrero. (2021) Systematic review and meta‐analysis on the impact of the levonorgestrel‐releasing intrauterine system in reducing risk of ovarian cancer. International Journal of Gynecology & Obstetrics 156:3, pages 418-424.
Crossref
Lauren A. King, Kara A. Michels, Barry I. Graubard & Britton Trabert. (2021) Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017. Cancer Causes & Control 32:6, pages 587-595.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.